Joep Muijrers has over two decades of broad experience in healthcare, including senior roles in portfolio management, company operations and investment banking. In his role as General Partner at Gilde healthcare, he focuses on investing in healthcare companies that can provide better care at lower cost. He is also responsible for managing Gilde’s Impact Council, which consists of world-leading experts who advise Gilde and its portfolio companies on key regulatory topics, cost effectiveness analyses, patient preferences, etc.
Before joining Gilde Healthcare, he served as Chief Financial Officer and Chief of Portfolio Strategy at PureTech Health, a Boston-based publicly-traded company. Prior to PureTech, Joep worked as Partner and Portfolio Manager at LSP (Life Sciences Partners; now part of EQT) where he invested in healthcare companies. Prior to joining LSP, Joep gained experience as an investment banker, and obtained his Ph.D. in Molecular Biology from the European Molecular Biology Laboratory (EMBL). Joep has been an invited speaker at events organized by the European Medicines Agency, NICE, ISPOR, BioCentury, Economist, BIO, DIA and other organizations. He has served on the Board of Directors of seven healthcare companies and as an advisor to two not-for-profit entities.
